Schultes Birgit C
EVP, Chief Scientific Officer at NTLA
- Sold, on record
- $79k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jan 5, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NTLAIntellia Therapeutics, Inc.EVP, Chief Scientific Officer
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NTLANo planOct 1, 2025 2025
Sold 31 shares at $17.38 ($539)
Schultes Birgit C, EVP, Chief Scientific Officer
No 10b5-1 planSold 0% of holdings ($1.8M position)105,184 shares leftFirst sale on recordFiling
- 2 Form 4 sale NTLANo planJan 5, 2026 +96 days
Sold 8,508 shares at $9.21 ($78k)
Schultes Birgit C, EVP, Chief Scientific Officer
No 10b5-1 planSold 7.9% of holdings ($986k position)98,533 shares leftFiling
Every transaction
Loading transactions…